Class vaccines and sera
Upcoming SlideShare
Loading in...5
×
 

Class vaccines and sera

on

  • 57 views

 

Statistics

Views

Total Views
57
Slideshare-icon Views on SlideShare
57
Embed Views
0

Actions

Likes
0
Downloads
6
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Class vaccines and sera Class vaccines and sera Presentation Transcript

    • Dr. RAGHU PRASADA M S MBBS,MD ASSISTANT PROFESSOR DEPT. OF PHARMACOLOGY SSIMS & RC. 1
    •  Immunity  Antigen-capsules ,cell walls ,toxins viral capsids, flagella,pollen  Vaccines -  Serum  Antiserum –rabbit,horse ,goat  Serum sickness  Toxoids
    •  Vaccines are immunobiological substances designed to produce specific protection against a given disease. It stimulates production of protective antibody and other immune mechanism
    •  HISTORY-SMALL POX-1798  RABIES-1885  TYPHOID -1896  CHOLERA- 1896  PLAGUE-1897  POLIO-1955  HEPATITIS-1981
    •  LIVE ATTENUATED VACCINES  Bacterial –bcg, typoid oral ,plague  Viral –polio yellow fever, measles  -rubella ,mumps ,influenza  KILLED VACCINES  Bacterial -Typhoid ,cholera ,Pertusis ,plague  Viral – rabies,salk(polio),  Influenza, hepatitis B,  Japanese encephalitis
    • LIVE ATTENUATED  Vaccine dose-low  Antibody persistence-long  Booster needed - infrequently  Revaccination –possible  Latency-possible  Oncogenicity- KILLEDVACCINES  High  Short  Frequently  None  None  none
    •  Birth –bcg +opv+hepatitis B  At 6 wks-DPT+OPV+HEP-B  At 10, 14 wks-DPT+OPV  At 6 months-hepatitis B  At 9 months-measles  At 15 months-DPT+OPV+MMR  At 4-5 years-DT-DA+OPV  At 10 years-TT+TAB/Ty21a  At 16 years-TT
    •  -attenuated live vaccine  Bovine strain of M.Tuber  0.5-1mg -1-2.5*107 colony forming units injected intracutaneously  Partial immunity  C/I—compromised host defence
    •  -produces active immunity  Induces systemic and intestinal immunity  Simultaneous administration to all infants  -avoid in vomiting and diarrhea  INACTIVATED POLIO VACCINE  -primary immunization in adults  persons with compromised immune system
    •  -prepared in yeast cells by recombinant DNA technique  three injections -0,1,6 months  -20µg in 1ml amp  HEPATITIS A VACCINE  -human diploid cell culture  0.5ml im  Booster after 6 months
    •  Mixed antigen – of Alum pptd toxoids of tetanus and diptheria available in 0.5 ml ampule and 5 ml vial  -diptheria toxoid is modified diptheria exotoxin adsorbed on to aluminium hydroxide  Tetanus toxoid is formalin treated exotoxin of tetanus baccilli  Diptheria toxoid 25 lf  Tetanus toxoid -5 lf  Pertusis-20000 million in 0.5 ml ampule
    •  Measles vaccine is grown on chick embryo ,- single dose 1000tcid  Mumps virus is grown in chick embryo ,single dose -5000 tcid . Clinical disease may occur if vaccinated after infection  Live attenuated rubella virus wistar RA 27/3 strain 1000 tcid per 0.5 ml inj  Single dose sc over deltoid >12 mnth children  C/I- pregnancy
    •  Antirabies vaccine carbolised (semple)  Neural tissue vaccine(NTV), is 5% suspension of sheep brain tissue  Need 14 daily painful large volume 2-5ml injectn-AAW  PCEV(purified chick embryo cell vaccine)  Rabies virus grown on chick fibroblast and inactivated by B-propiolactone available as 2.5IU in 1ml amp  Human diploid cell vaccine (HDCV)  Lyophilised inactivated rabies virus –  Grown on human diploid cell culture  Purified vero cell vaccine (PVRV)
    •  Sterile suspension -1ml containing 1*109 S.typhi and 7.5*108 each of S.paratyphi A and B dose- 0.5ml sc  TYPHOID TY21A ORAL VACCINE  Newer live oral typhoid vaccine prepared from Ty21a attenuated strain of S.typhi  Absence of enzyme uridine di phosphate galactose 4 epimerase
    •  From horse-tetanus antitoxin(ATS) -gas gangrene antitoxin(AGB) -diphtheria antitoxin (ADS) Immunoglobins (humans ) Normal human gamma globin Anti-D immunoglobin Tetanus immunoglobin Rabies immunoglobin Hepatitis B immunoglobin
    •  Concentrated Ig from human plasma  Viral hepatitis A and B ,measles ,mumps  Agammaglobulinemia  Augument the response to antibodies  ANTI-D IMMUNOGLOBULIN  Tetanus immunoglobulin indicated for prophylaxis in non-immunised persons  Better than equine ATS  Treatment of clinical tetanus  Dose-3000-6000 IU
    •  Anti rabies serum(ARS)  Equine Rabies Immunoglobin (ERIG)  after suspected exposure  Dose- 40 IU /kg infiltration around the wound  RABIES IMMUNOGLOBULIN HUMAN  -superior to ARS with longer t1/2  Passive protection is needed as active immunity takes 2 weeks
    •  Antibodies to hep-b surface antigen  Better than human gamma globulin  Used in individuals acutely exposed to Hbs Ag positive blood Hep B vaccine should be given concurrently  dose -1000-2000 IU 32-48 IU/kg
    •  Serum polyvalent  purified ,concentrated equine globulins in lyophilised vials  each ml neutralises  0.6 mg of Std.cobra venom  0.6 mg of Std.Russel viper  0.45 mg of Std saw scaled viper  0.45 mg of Std .Krait